HES treatment in an ovalbumin (OVA)-induced asthma mouse model reduced IL-4, IL-5, IL-13, and IL-17 production, as well as OVA-specific IgE expression by inhibition of the GATA binding protein 3 (GATA3) transcription factor to the DNA. The gene discussed is GATA3; the disease is asthma.